Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: A histopathological cohort study.

MLA

Lessard, Lola E. R., et al. “Contribution of Major Histocompatibility Complex Class II Immunostaining in Distinguishing Idiopathic Inflammatory Myopathy Subgroups: A Histopathological Cohort Study.” Journal of Neuropathology and Experimental Neurology, vol. 83, no. 12, Dec. 2024, pp. 1060–75. EBSCOhost, https://doi.org/10.1093/jnen/nlae098.

APA

Lessard, L. E. R., Robert, M., Fenouil, T., Mounier, R., Landel, V., Carlesimo, M., Hot, A., Chazaud, B., Laumonier, T., Streichenberger, N., & Gallay, L. (2024). Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: A histopathological cohort study. Journal of Neuropathology and Experimental Neurology, 83(12), 1060–1075. https://doi.org/10.1093/jnen/nlae098

Chicago

Lessard, Lola E R, Marie Robert, Tanguy Fenouil, Rémi Mounier, Véréna Landel, Marie Carlesimo, Arnaud Hot, et al. 2024. “Contribution of Major Histocompatibility Complex Class II Immunostaining in Distinguishing Idiopathic Inflammatory Myopathy Subgroups: A Histopathological Cohort Study.” Journal of Neuropathology and Experimental Neurology 83 (12): 1060–75. doi:10.1093/jnen/nlae098.